Skin AgingNCT04532437
Computer-based Skin Aging Simulation for Skin Cancer Prevention
An observational study of Skin Aging, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
Trial summary
This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention. Read more about this study
- Who is it for?
- Ages 18 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Skin Aging
- What is being tested?
- artificial intelligence-based skin aging simulation, electronic questionnaire 1 and electronic questionnaire 2
- How many people
- 60 participants
- Where
- 1 siteSwitzerland
- Study dates
- 9 Feb 2021to 19 Mar 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: Young healthy female volunteers aged 18-35 years, e.g. medical students of the University Basel, who do not have any skin diseases requiring medical therapy
Who may be able to join
- healthy female volunteers
- written,Institutional Review Board (IRB)/ Independent Ethics Committee (IEC)-approved informed consent.
Who cannot join
- skin diseases requiring medical therapy
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Department of Dermatology, University Hospital Basel
Basel, 4031
About this study
Official title: Computer-based Skin Aging Simulation for Skin Cancer Prevention: A Pilot Study
This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.
Read the detailed description
In young adulthood an increasing UV-exposure often starts because of the belief that tanning increases attractiveness]. Raising awareness and educating students and adults regarding practices for skin cancer prevention are critical since skin cancer is increasing rapidly worldwide. Skin cancer preventive interventions for adolescents are needed to improve their motivation for sun safety behavior. This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.
- Conditions
- Skin Aging
- Being tested
- artificial intelligence-based skin aging simulation, electronic questionnaire 1, electronic questionnaire 2
- Keywords
- skin cancer prevention, skin aging simulation, UV-exposure, skin analysis photo system, VISIA® photo analysis system
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
artificial intelligence-based skin aging simulationOther
Photographs of the volunteers' facial skin will be taken in the Department of Dermatology at baseline using a modern skin analysis photo system (VISIA®, Canfield Scientific, Parsippany, NJ, USA) and afterwards a simulation of the participants' facial skin aging will be performed with the VISIA® photo analysis System.
electronic questionnaire 1Other
Electronic questionnaire about current sun-related knowledge and protective behaviours via link with smartphone before and after the skin aging simulation.
electronic questionnaire 2Other
Participants report their perception of the interventions and their motivation for improved sun protection by completing an electronic questionnaire after the skin aging simulation.
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in visual analogue scale (VAS) score regarding importance of UV- protection
Change in VAS score regarding importance of UV- protection (0 = not important; 10 = extremly important)
Measured: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
Change in VAS score regarding rating of personal exposure to UV radiation
Change in VAS score regarding rating of personal exposure to UV radiation (0 = no exposure; 10 = very high exposure)
Measured: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
Secondary outcomes (2)
Questionnaire asking for reduction of UV- exposure (yes/no)
Questionnaire asking for reduction of UV- exposure (yes/no)
Measured: after the skin aging simulation (each scoring session will take about 15-20 minutes)
Questionnaire asking for intensification of UV protection measures (yes/ no)
Questionnaire asking for intensification of UV protection measures (yes/ no)
Measured: after the skin aging simulation (each scoring session will take about 15-20 minutes)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Aug 2020
- Study start9 Feb 2021
- Primary completion19 Mar 2021
- Study completion19 Mar 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Lara Valeska Maul, Dr. med., Principal investigator, Department of Dermatology, University Hospital Basel
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04532437
- Sponsor's protocol ID
- Req-2020-00963; sp20Maul3
- Status last verified
- Dec 2021
- First submitted
- 25 Aug 2020
- Last updated
- 15 Dec 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Dec 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Computer-based Skin Aging Simulation for Skin Cancer Prevention: A Pilot Study
- ClinicalTrials.gov ID
- NCT04532437
- Acronym / sponsor ID
- Req-2020-00963; sp20Maul3
- Conditions
- Skin Aging
- Keywords
- skin cancer prevention, skin aging simulation, UV-exposure, skin analysis photo system, VISIA® photo analysis system
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- University Hospital, Basel, SwitzerlandUniversity, hospital or other
- Study start
- 9 Feb 2021 (actual)
- Primary completion
- 19 Mar 2021 (actual)
- Study completion
- 19 Mar 2021 (actual)
- First posted
- 31 Aug 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.
Detailed description
In young adulthood an increasing UV-exposure often starts because of the belief that tanning increases attractiveness]. Raising awareness and educating students and adults regarding practices for skin cancer prevention are critical since skin cancer is increasing rapidly worldwide. Skin cancer preventive interventions for adolescents are needed to improve their motivation for sun safety behavior. This pilot study is to assess the knowledge, attitudes, and practices regarding skin cancer prevention in young adults and to determine the impact of artificial intelligence-based simulation of facial skin aging on their attitudes regarding skin cancer prevention.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Young healthy female volunteers aged 18-35 years, e.g. medical students of the University Basel, who do not have any skin diseases requiring medical therapy
Key inclusion criteria (2 listed)
- healthy female volunteers
- written,Institutional Review Board (IRB)/ Independent Ethics Committee (IEC)-approved informed consent.
Key exclusion criteria (1 listed)
- skin diseases requiring medical therapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| artificial intelligence-based skin aging simulationPhotographs of the volunteers' facial skin will be taken in the Department of Dermatology at baseline using a modern skin analysis photo system (VISIA®, Canfield Scientific, Parsippany, NJ, USA) and afterwards a simulation of the participants' facial skin aging will be performed with the VISIA® photo analysis System. | Other | – |
| electronic questionnaire 1Electronic questionnaire about current sun-related knowledge and protective behaviours via link with smartphone before and after the skin aging simulation. | Other | – |
| electronic questionnaire 2Participants report their perception of the interventions and their motivation for improved sun protection by completing an electronic questionnaire after the skin aging simulation. | Other | – |
Primary outcome
Change in visual analogue scale (VAS) score regarding importance of UV- protection
Time frame: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
Change in VAS score regarding importance of UV- protection (0 = not important; 10 = extremly important)
Change in VAS score regarding rating of personal exposure to UV radiation
Time frame: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)
Change in VAS score regarding rating of personal exposure to UV radiation (0 = no exposure; 10 = very high exposure)
2 secondary outcomes
Questionnaire asking for reduction of UV- exposure (yes/no)
Time frame: after the skin aging simulation (each scoring session will take about 15-20 minutes)
Questionnaire asking for intensification of UV protection measures (yes/ no)
Time frame: after the skin aging simulation (each scoring session will take about 15-20 minutes)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Dec 2021.
Related trials for Skin Aging
Recruiting
Ultraformer MPT Combined With Fractional CO2 Versus Fractional CO2 Alone for Facial Rejuvenation
Skin Aging
Enrolling by invitationEarly Phase 1
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
Aging
Not yet recruiting
Effects of Probiotics on Skin Health in Healthy Women
Skin Aging, Dry Skin
Not yet recruiting
Evaluation of MD60002 Device for Facial Skin Aging
Facial Wrinkles, Skin Aging
RecruitingPhase 3
Safety and Effectiveness of NOA HYDRATION Injectable Gel for the Improvement of Skin Quality Including Attributes Such as Skin Smoothness
Skin Quality
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lara Valeska Maul, Dr. med. principal investigator
Department of Dermatology, University Hospital Basel
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Skin Aging, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in visual analogue scale (VAS) score regarding importance of UV- protection (time frame: before and after the skin aging simulation (each scoring session will take about 15-20 minutes)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2021.